✦ LIBER ✦

Phase 2 comparison of a novel ammonia scavenging agent with sodium phenylbutyrate in patients with urea cycle disorders: Safety, pharmacokinetics and ammonia control

✍ Scribed by Brendan Lee; William Rhead; George A. Diaz; Bruce F. Scharschmidt; Asad Mian; Oleg Shchelochkov; J.F. Marier; Martin Beliveau; Joseph Mauney; Klara Dickinson; Antonia Martinez; Sharron Gargosky; Masoud Mokhtarani; Susan A. Berry

Book ID: 116988983
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 296 KB
Volume: 100
Category: Article
ISSN: 1096-7192
DOI: 10.1016/j.ymgme.2010.03.014

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ammonia control in children with urea cy

Ammonia control in children with urea cycle disorders (UCDs); Phase 2 comparison of sodium phenylbutyrate and glycerol phenylbutyrate

✍ Uta Lichter-Konecki; G.A. Diaz; J.L. Merritt II; A. Feigenbaum; C. Jomphe; J.F. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 406 KB

Ammonia Control in Children Ages 2 Month

Ammonia Control in Children Ages 2 Months through 5 Years with Urea Cycle Disorders: Comparison of Sodium Phenylbutyrate and Glycerol Phenylbutyrate

✍ Smith, Wendy; Diaz, George A.; Lichter-Konecki, Uta; Berry, Susan A.; Harding, C 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 415 KB

Population Pharmacokinetic Modeling and

Population Pharmacokinetic Modeling and Dosing Simulations of Nitrogen-Scavenging Compounds: Disposition of Glycerol Phenylbutyrate and Sodium Phenylbutyrate in Adult and Pediatric Patients with Urea Cycle Disorders

✍ Monteleone, Jon P. R.; Mokhtarani, M.; Diaz, G. A.; Rhead, W.; Lichter-Konecki, 📂 Article 📅 2013 🏛 Sage Publications 🌐 English ⚖ 1001 KB

Glycerol phenylbutyrate treatment in chi

Glycerol phenylbutyrate treatment in children with urea cycle disorders: Pooled analysis of short and long-term ammonia control and outcomes

✍ Berry, Susan A.; Lichter-Konecki, Uta; Diaz, George A.; McCandless, Shawn E.; Rh 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 959 KB

S1839 Pharmacokinetic (PK) and Safety An

S1839 Pharmacokinetic (PK) and Safety Analyses of a Novel Ammonia-Reducing Agent in Healthy Adults and Patients with Cirrhosis

✍ McGuire, Brendan M.; Gargosky, Sharron E.; Scharschmidt, Bruce F.; Syplyviy, Vas 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 109 KB

Efficacy and safety of monotherapy with

Efficacy and safety of monotherapy with the novel sodium/glucose cotransporter-2 inhibitor tofogliflozin in Japanese patients with type 2 diabetes mellitus: a combined Phase 2 and 3 randomized, placebo-controlled, double-blind, parallel-group comparative study

✍ Kaku, Kohei; Watada, Hirotaka; Iwamoto, Yasuhiko; Utsunomiya, Kazunori; Terauchi 📂 Article 📅 2014 🏛 BioMed Central 🌐 English ⚖ 316 KB